Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
29 September-02 October, 2025
Not Confirmed
Not Confirmed
29 September-01 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
29 September-02 October, 2025
Industry Trade Show
Not Confirmed
29 September-01 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers
17 Sep 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/mabwell-bioscience-and-aditum-bio-announce-formation-of-kalexo-bio-to-advance-innovative-sirna-therapy-for-cardiovascular-disorders-302558666.html
19 Aug 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/mabwells-cdh17-targeting-adc-7mw4911-receives-ind-clearance-from-fda-302533295.html
12 Aug 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/mabwell-announces-first-patient-dosed-in-the-us-clinical-study-of-bulumtatug-fuvedotin-in-tnbc-patients-previously-treated-with-adcs-302527599.html
01 Aug 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/mabwell-announces-ind-application-acceptance-for-cdh17-targeting-adc-7mw4911-from-both-nmpa-and-fda-302519602.html
27 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/mabwell-announces-novel-drug-technology-license-agreement-with-qilu-pharmaceutical-for-albipagrastim-alfa-for-injection-302493293.html
27 Jun 2025
// PRESS RELEASE
ABOUT THIS PAGE